Miguel Angel Berdún

Role of Weight-Based Ribavirin Dosing and Extended Duration of Therapy in Chronic Hepatitis C in HIV-Infected Patients: The PRESCO Trial

Marina Núñez, Celia Miralles, Miguel Angel Berdún et al. · AIDS Research and Human Retroviruses · 2007 · 189 citations

Baseline Serum Hepatitis C Virus (HCV) RNA Level and Response at Week 4 Are the Best Predictors of Relapse After Treatment With Pegylated Interferon Plus Ribavirin in HIV/HCV-Coinfected Patients

Marina Núñez, Angel Mariño, Celia Miralles et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2007 · 43 citations

Critical role of ribavirin for the achievement of early virological response to HCV therapy in HCV/HIV‐coinfected patients

Belén Ramos, Marina Núñez, Ana Lucía Rendón et al. · Journal of Viral Hepatitis · 2006 · 40 citations

Impact of Ribavirin Exposure on Early Virological Response to Hepatitis C Therapy in HIV-Infected Patients with Chronic Hepatitis C

Marina Núñez, Nuria Camino, Belén Ramos et al. · Antiviral Therapy · 2005 · 36 citations

Premature Treatment Discontinuation in HIV/HCV-Coinfected Patients Receiving Pegylated Interferon plus Weight-Based Ribavirin

Vincent Soriano, Celia Miralles, Miguel Angel Berdún et al. · Antiviral Therapy · 2007 · 21 citations · Full text